A silver jubilee for synthetic lethality in cancer treatment: where do we stand

被引：0
|
作者：
Lee, Joo Sang
Chung, Youngmin
Kammula, Ashwin V.
Schaffer, Alejandro A.
Ruppin, Eytan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-946
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
946
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Dithiolethiones for cancer chemoprevention: where do we stand?
    Zhang, Yuesheng
    Munday, Rex
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) : 3470 - 3479
  • [22] Magnesium treatment for asthma - Where do we stand?
    Noppen, M
    CHEST, 2002, 122 (02) : 396 - 398
  • [23] Lung cancer in Pakistan, where do we stand?
    Majeed, Farhan Ahmed
    Azeem, Abdul Rehman
    Farhan, Nabeela
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (03) : 405 - 408
  • [24] Marine Compounds and Cancer: Where Do We Stand?
    Dyshlovoy, Sergey A.
    Honecker, Friedemann
    MARINE DRUGS, 2015, 13 (09): : 5657 - 5665
  • [25] Heparins and cancer survival: where do we stand?
    Noble, Simon
    THROMBOSIS RESEARCH, 2014, 133 : S133 - S138
  • [26] Prevention and treatment of stroke: Where do we stand?
    Gibaldi, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (09): : 784 - 790
  • [27] Immunotherapy and immunoprevention of cancer: where do we stand?
    Cavallo, F
    Curcio, C
    Forni, G
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (05) : 717 - 726
  • [28] Breast cancer 2002: Where do we stand?
    Ganz, PA
    CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (05) : 253 - 255
  • [29] Where do we stand?
    Thompson, ID
    FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382
  • [30] Where do we stand?
    不详
    INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2010, 59 (03) : 79 - 86
12345